SERPINA3 as a Secreted-Protein Biomarker Associated with Poor Prognosis and T-Cell Dysfunction in Non-small Cell Lung Cancer
Tuberculosis and Respiratory Diseases · 01.07.2026 · 89 (3) · 403-415
DOI: 10.4046/trd.2026.0014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Tuberculosis and Respiratory Diseases, erschienen am 01.07.2026. Verfasst von Joon Kim und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, …. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Korean Academy of Tuberculosis and Respiratory Diseases.
Abstract (Originalsprache)
Background
Lung cancer remains the leading cause of cancer-related mortality, with poor outcomes driven by late presentation and therapy resistance. While genes encoding secreted proteins may reflect tumor biology and have biomarker potential, systematic multi-cohort studies that identify and validate prognostically relevant secreted protein candidates in non-small cell lung cancer (NSCLC) are limited.
Methods
We conducted a multi-cohort transcriptomic screen of 1,896 genes encoding secreted proteins to nominate prognostic candidates in NSCLC. Candidates were prioritized based on differential expression between tumor and normal tissues and survival associations across public NSCLC cohorts. Serpin family A member 3 (SERPINA3) was selected for further validation in The Cancer Genome Atlas (TCGA) NSCLC dataset. Tumors were stratified by SERPINA3 expression for Kaplan–Meier survival analysis and gene set enrichment analysis (GSEA) using the Hallmark and Kyoto Encyclopedia of Genes and Genomes (KEGG) collections. Translational relevance was assessed in a retrospective bronchoalveolar lavage fluid (BALF) registry using multivariable Cox models.
Results
In the TCGA NSCLC dataset, SERPINA3-high tumors had shorter overall survival (OS; log-rank p=0.016) and progression-free survival (PFS; log-rank p=0.018). GSEA showed enrichment in tumor necrosis factor-α/nuclear factor-κB, inflammatory response, interleukin 6 (IL-6)–Janus kinase (JAK)–signal transducer and activator of transcription 3 (STAT3), and IL-17 signaling pathways. The SERPINA3-high state exhibited a T-cell–infiltrated, checkpoint-high phenotype consistent with T-cell dysfunction, characterized by increased levels of transforming growth factor-β, IL-10, and indoleamine 2,3-dioxygenase (IDO). In the BALF registry, higher BALF—but not plasma—SERPINA3 independently predicted shorter PFS, with a nonsignificant trend toward OS after adjustment.
Conclusion
Across datasets, SERPINA3 indicates an immune-inflammatory tumor state associated with worse survival. BALF-based measurement captured tumor-proximal signals that may be less apparent in plasma, supporting its potential clinical utility for risk stratification and warranting prospective validation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
- Division of Pulmonology, Department of Internal Medicine, Inha University Hospital, Inha University College of Medicine, Incheon, Republic of Korea.
- Department of Biomedical Science and Engineering, Gwangju Institute of Science and Technology, Gwangju, Republic of Korea.
- Department of Biomedical Science and Engineering, Gwangju Institute of Science and Technology, Gwangju, Republic of Korea. cmoh@gist.ac.kr.
- Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea. cloud9@yuhs.ac.
Förderung
- Korean Academy of Tuberculosis and Respiratory Diseases
Zitieren
APA
Kim, J., Lee, G., Yong, S. H., Kim, E. Y., Jo, Y., Jeong, W., Ryu, D., Oh, C. M., & Lee, S. H. (2026). SERPINA3 as a Secreted-Protein Biomarker Associated with Poor Prognosis and T-Cell Dysfunction in Non-small Cell Lung Cancer. Tuberculosis and Respiratory Diseases, 89(3), 403-415. https://doi.org/10.4046/trd.2026.0014
Vancouver
Kim J, Lee G, Yong SH, Kim EY, Jo Y, Jeong W, et al. SERPINA3 as a Secreted-Protein Biomarker Associated with Poor Prognosis and T-Cell Dysfunction in Non-small Cell Lung Cancer. Tuberculosis and Respiratory Diseases. 2026;89(3):403-415. doi:10.4046/trd.2026.0014
BibTeX
@article{Kim2026,
author = {Kim, Joon and Lee, Geunin and Yong, Seung-Hyun and Kim, Eun Young and Jo, Yunju and Jeong, Wooju and Ryu, Dongryeol and Oh, Chang-Myung and Lee, Sang Hoon},
title = {SERPINA3 as a Secreted-Protein Biomarker Associated with Poor Prognosis and T-Cell Dysfunction in Non-small Cell Lung Cancer},
journal = {Tuberculosis and Respiratory Diseases},
year = {2026},
volume = {89},
number = {3},
pages = {403--415},
doi = {10.4046/trd.2026.0014}
}
EUVIMED